Ambalal Sarabhai Enterprises Ltd.
Snapshot View

View in App

Prices View details

32.40 +1.70 ▲5.5%

27 June 2022, 04:01:00 PM
Volume: 95,954

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ase.life
Market Cap 248.29 Cr.
Enterprise Value(EV) 245.66 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 6.16 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 5.26 Trailing Twelve Months Ending 2022-03
Industry PE 29.84 Trailing Twelve Months Ending 2022-03
Book Value / Share 15.64 Trailing Twelve Months Ending 2022-03
Price to Book Value 2.07 Calculated using Price: 32.40
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 7.66 Cr. 76,633,296 Shares
FaceValue 10
Company Profile
Ambalal Sarabhai Enterprises is a Baroda-based pharmaceutical manufacturing company which was incorporated in 1977. It is one of the company belonging to the Sarabhai Group. The Group's principal activity is manufacture and marketing of pharmaceutical products and bulk drugs. The company's plants are located at Vadodara and Ahmedabad.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+5.54%
1 Week
+13.49%
1 Month
+4.52%
3 Month
+1.73%
6 Month
-1.97%
1 Year
-9.50%
2 Year
+92.86%
5 Year
+278.50%
10 Year
+825.71%

Ratios View Details

9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) -66.09 -256.13 328.25 -57.92 4.20 7.01 40.95 34.12
Return on Capital Employed (%) -12.98 -17.91 10.08 107.14 -11.94 16.34 13.17 27.14 29.83
Return on Assets (%) -8.29 -9.58 -3.51 25.83 -10.30 0.62 0.99 7.84 10.36

Balance Sheet View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 18 -2 -9 39 25 27 31 45 74 120
Non Curr. Liab. 17 59 15 13 6 11 9 5 5 5
Curr. Liab. 175 155 163 153 124 155 171 133 129 105
Minority Int. 0 0 0 0
Equity & Liab. 210 211 169 204 155 193 211 183 208 230
Non Curr. Assets 106 144 100 92 82 80 95 79 87 110
Curr. Assets 105 67 68 112 73 114 116 104 121 120
Misc. Exp. not W/O
Total Assets 210 211 169 204 155 193 211 183 208 230

Profit Loss View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 100 105 125 132 134 125 152 134 164 197
Other Income 16 3 13 95 6 25 5 24 31 42
Total Income 117 108 137 227 140 150 157 158 194 239
Total Expenditure -111 -113 -129 -145 -145 -137 -146 -135 -165 -172
PBIDT 6 -6 9 82 -5 13 11 22 29 67
Interest -9 -11 -10 -4 -5 -3 -3 -4 -3 -2
Depreciation -14 -3 -5 -17 -4 -2 -2 -3 -2 -2
Taxation -1 -1 -1 -14 -5 -7 -4 -1 -3 -7
Exceptional Items -15
PAT -18 -20 -7 48 -19 1 2 15 20 41
Minority Interest
Share Associate 0 0 2 -1 9 6
Other Related Items
Consolidated Net Profit -18 -20 -7 48 -18 1 4 14 29 47
Adjusted EPS -2 -3 -1 6 -2 0 1 2 4 6

Cash Flow View Details

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. -13 -3 11 -8 -75 5 -7 19 -7 -2
Cash Fr. Inv. 11 0 -1 10 80 -3 18 -9 17 10
Cash Fr. Finan. 1 3 -8 -1 -3 -6 -2 -6 -14 -6
Net Change -1 -1 2 1 2 -4 8 3 -4 2
Cash & Cash Eqvt 7 6 8 8 10 5 14 17 13 15

Shareholding Pattern View Details

9 Qtrs 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 30.76 30.76 30.76 30.76 30.76 30.76 30.76 30.76 30.76
Public 69.24 69.24 69.24 69.24 69.24 69.24 69.24 69.24 69.24
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Thu, 09 Jun 2022
Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The SEBI (LODR) Regulations 2015 For The Half Year Ended March 31 2022.
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirement) Regulations 2015 please find enclosed herewith disclosure of Related Party Transactions on a consolidated basis for the half year ended March 31 2022. Kindly take the same on record.
Mon, 30 May 2022
Compliances-Reg.24(A)-Annual Secretarial Compliance
Please find enclosed herewith Annual Secretarial Compliance Report of the Company pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 issued by RPAP & Co Practicing Company Secretaries Ahmedabad for the financial year ended March 31 2022 read with SEBI Circular no. CIR/CFD/CMD1/27/2019 dated February 08 2019. We request you to kindly take the same on record & oblige.
Mon, 30 May 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
This is to inform you that in compliance with Regulation 30 & 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are enclosing herewith the copies of Newspaper Clippings of the publication of the Extract of the Audited Financial Results (Standalone and Consolidated) for the Quarter and Year ended on March 31 2022 published in The Economic Times (English) & Nav Gujarat Samay (Gujarati) - Ahmedabad on May 27 2022. Please take the same on record.

Technical Scans View Details

Mon, 27 Jun 2022
High Delivery Percentage High Delivery Percentage
Close Crossing Last Week High Close Crossing Last Week High
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 200,572.41 835.95 +1.4%
Divi's Laboratories Ltd. 97,518.56 3,679.05 0.0%
Cipla Ltd. 75,086.75 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. 71,855.08 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. 54,559.09 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. 48,438.53 2,858.25 -0.6%
Gland Pharma Ltd. 43,775.42 2,658.60 +0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 61.29 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 32.99 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 29.83 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 32.92 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 51.70 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 62.24 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 36.13 2,658.60 +0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 4.18 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8.33 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 3.60 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 3.74 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 9.68 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8.12 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 6.12 2,658.60 +0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 0.08 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 0.10 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 0.62 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 0.84 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 0.00 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 33,498.14 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 19,159.59 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 10,560.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 8,004.83 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 3,462.88 2,658.60 +0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 2,284.68 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 2,401.30 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 136.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 1,251.88 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 996.96 2,658.60 +0.6%

FAQ's On Ambalal Sarabhai Enterprises Ltd.

Can I Buy Ambalal Sarabhai Ent Shares now?
What is the Share Price of Ambalal Sarabhai Ent?
What is the Relative Strength Index (RSI) Value of Ambalal Sarabhai Ent?
What is the Market Capital (MCAP) of Ambalal Sarabhai Ent?
What are the key metrics to analyse Ambalal Sarabhai Ent?
What is the Price Performance of Ambalal Sarabhai Ent?